Maghami Zohreh; Mozhdeh Sepaskhah; Sarani Ebrahim Moghimi; Bagheri Zahra; Maghami Mohamad
Abstract
Background: Vitiligo is a common pigmentary disorder affecting mental health, and alexithymia is a trait associated with multiple cutaneous disorders. This study was conducted to compare vitiligo patients and controls as concerns alexithymia. Methods: Fifty-two patients with vitiligo and 61 non-vitiligo ...
Read More
Background: Vitiligo is a common pigmentary disorder affecting mental health, and alexithymia is a trait associated with multiple cutaneous disorders. This study was conducted to compare vitiligo patients and controls as concerns alexithymia. Methods: Fifty-two patients with vitiligo and 61 non-vitiligo individuals were recruited. They completed Toronto alexithymia score-20 questionnaire. Independent sample t-test and Chi-square tests were used for comparing numerical and categorical variables, respectively. P value ? 0.05 was considered statistically significant. Results: Twenty vitiligo patients were alexithymic, while 14 were borderline alexithymic. Thirteen, 16, and 32 control people were alexithymic, borderline alexithymic and non-alexithymic, respectively (p value: 0.096). Although alexithymia and borderline alexithymia were not significantly more prevalent in vitiligo patients (p value: 0.57), they were more likely to be high alexithymic (TAS ? 61) compared with the control group (p value: 0.02). Comparisons with the controls, patients obtained significantly higher scores associated with subscales of difficulty in identifying feelings (DIF) and difficulty in describing feelings (DDF) (p value: 0.002 and 0.02 respectively). Patients with lower education obtained higher alexithymia scores (p value: 0.009). Conclusion: High alexithymia and higher DIF and DDF subscales are more prevalent in vitiligo patients in comparison with control population. Patients with lower levels of education are more alexithymic.
Sepaskhah Mozhdeh; Maghami Zohreh
Volume 18, Issue 4 , 2015, , Pages 179-181
Abstract
Pityriasis lichenoides is an uncommon, acquired, papulosquamous disorder that exhibits various clinical presentations, including acute, chronic, and febrile ulceronecrotic Mucha- abermann forms. Pityriasis lichenoides chronica (PLC) is the chronic form of this continuum. Its treatment is challenging ...
Read More
Pityriasis lichenoides is an uncommon, acquired, papulosquamous disorder that exhibits various clinical presentations, including acute, chronic, and febrile ulceronecrotic Mucha- abermann forms. Pityriasis lichenoides chronica (PLC) is the chronic form of this continuum. Its treatment is challenging for patients and clinicians and some cases are multidrug resistant. Today, this disorder has many treatment choices, including topical corticosteroids, topical calcineurin inhibitors, phototherapy (ultraviolet (UV) A and narrow band UVB), methotrexate, dapsone, cyclosporine and recently etanercept. In our experience, mycophenolate mofetil was effective as a new treatment for pityriasis lichenoides.